111 related articles for article (PubMed ID: 1009612)
21. [Induction of chromosome aberrations and mitotic disorders in a bone marrow cell culture of Papio hamadryas in exposure to cytochalasin B].
Markarian DS; Malpoix P
Tsitologiia; 1982 Jul; 24(7):814-8. PubMed ID: 7135481
[TBL] [Abstract][Full Text] [Related]
22. [Nursing of gynecological patients treated by chemotherapy].
Xian M
Zhonghua Hu Li Za Zhi; 1985 Jun; 20(3):156-8. PubMed ID: 3849358
[No Abstract] [Full Text] [Related]
23. [Registration of cytostatic effects in vitro by means of an objective method of cell counting (ZZV) (author's transl)].
Krafft W; Preibsch W; Marzotko F; Niedner K
Arch Geschwulstforsch; 1974; 44(2):140-3. PubMed ID: 4476203
[No Abstract] [Full Text] [Related]
24. [Cytostatic chemotherapy in advanced age].
Sauer H
Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):M1-5. PubMed ID: 7705590
[No Abstract] [Full Text] [Related]
25. Severe, prolonged bone marrow hypoplasia secondary to the use of carboplatin in an azotemic dog.
Phillips B
J Am Vet Med Assoc; 1999 Nov; 215(9):1250-2; discussion 1252-3. PubMed ID: 10553432
[No Abstract] [Full Text] [Related]
26. [Influence of insulin on the mitotic activity of the bone marrow cells following irradiation].
Barkalaia AI
Med Radiol (Mosk); 1976 Feb; 21(2):78-9. PubMed ID: 1250093
[No Abstract] [Full Text] [Related]
27. [The proliferative activity of leukemic blast cells in the bone marrow and peripheral blood (author's transl)].
Tsuchiya J; Moteki M; Sato S; Shimano S; Onogaki Y
Rinsho Ketsueki; 1974 Aug; 15(8):851-7. PubMed ID: 4531496
[No Abstract] [Full Text] [Related]
28. [Treatment of neoplasms of the hematopoietic system based on some principles of cytokinetics].
Traczyk Z
Acta Haematol Pol; 1974; 5(1):85-90. PubMed ID: 4595062
[No Abstract] [Full Text] [Related]
29. Complications of cytotoxic antineoplastic chemotherapy.
White DR; Cooper MR; Muss HB; Richards F; Spurr CL
N C Med J; 1979 Feb; 40(2):73-8. PubMed ID: 370616
[No Abstract] [Full Text] [Related]
30. [Selenium, aflatoxins and lymphocyte reactivity (author's transl)].
Aleksandrowicz J; Lisiewicz J; Skotnicki A; Waszek Z
Folia Clin Int (Barc); 1974 Nov; 24(11):795-6. PubMed ID: 4435282
[No Abstract] [Full Text] [Related]
31. [Replacement therapy with blood components in bone-marrow depression due to cytostatic drugs (author's transl)].
Höcker P; Pittermann E; Mann M; Krasa E
Wien Klin Wochenschr; 1980 Aug; 92(15):530-5. PubMed ID: 7001766
[TBL] [Abstract][Full Text] [Related]
32. The effect of cis-platinum (II) diamminodichloride on bone marrow.
Zák M; Drobník J; Rezný Z
Cancer Res; 1972 Mar; 32(3):595-9. PubMed ID: 5061310
[No Abstract] [Full Text] [Related]
33. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.
Ledzewicz U; Schättler H
Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967
[TBL] [Abstract][Full Text] [Related]
34. [The treatment of longcarcinoma with antimitotics (author's transl)].
Verstraeten JM
Acta Tuberc Pneumol Belg; 1975; 66(4-5):380-3. PubMed ID: 1233020
[No Abstract] [Full Text] [Related]
35. [Disturbances of mitotic activity in hemohistoblasts of the bone marrow during acute radiation injury and under the effects of chemical mutagenic agents].
Gol'dberg ED; Gol'dberg DI; Golubev IV
Arkh Patol; 1967; 29(2):25-30. PubMed ID: 4973501
[No Abstract] [Full Text] [Related]
36. [Cytogenetic analysis of bone marrow cells of rats during action of herbicides of the group symm-triazine].
Kulakov AE
Farmakol Toksikol; 1970; 33(2):224-7. PubMed ID: 5425634
[No Abstract] [Full Text] [Related]
37. [Early clinical experiments on the anti-mitotic activity of griseofulvin in cancer chemotherapy].
Huant E
Therapie; 1967; 22(5):1143-51. PubMed ID: 5583622
[No Abstract] [Full Text] [Related]
38. [Use of autologous bone marrow in patients with cancer of the female reproductive organs for depression of heatopoiesis following chemo- and radiotherapy].
Korotia TA
Vrach Delo; 1971 Apr; 7():85-8. PubMed ID: 4946450
[No Abstract] [Full Text] [Related]
39. [Acute myelogenous leukaemia: prognostic value of infectious complications observed during the induction treatment (author's transl)].
Reiffers J; Vezon G; Broustet A
Sem Hop; 1981 Jan 18-25; 57(3-4):133-7. PubMed ID: 6261351
[TBL] [Abstract][Full Text] [Related]
40. [Allogeneic stem cell transplantation. A valuable alternative after myeloablative chemotherapy].
Unterhuber R
Fortschr Med; 1996 May; 114(14):175-6. PubMed ID: 8707236
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
